Apogee Therapeutics APGE
NASDAQ APGE
$135.07 -0.01 (-0.01%)
At close: Sep 2, 2026 · 4:00 PM EDT

Apogee Therapeutics (APGE) Other Operating Expenses (2026)

Analysis

Apogee Therapeutics (APGE) Other Operating Expenses (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Apogee Therapeutics 10.18 Bn 9.20 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.36 Mn